Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919425 · ClinicalTrials.gov registry record
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
A clinical trial of Leukemia and Myelodysplastic Syndromes, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 1,294
- Enrollment target
- 20
- Study locations
NCT00919425 is a study of Leukemia and Myelodysplastic Syndromes that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 1,294 participants, above the 481-participant average among 233 other Leukemia trials with a reported enrollment target (169% higher). The trial reports 20 study locations across 6 states.
The verdict
NCT00919425, a study of Leukemia and Myelodysplastic Syndromes, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 1,294 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment. PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with hematologic cancer to be tested in the laboratory.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
California
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center - Burbank
- Peninsula Medical Center - Burlingame
- North Bay Cancer Center - Fairfield
- Sutter Health - Western Division Cancer Research Group - Novato
- University of California Davis Cancer Center - Sacramento
- California Pacific Medical Center - California Campus - San Francisco
- Stanford Cancer Center - Stanford
- Sutter Solano Medical Center - Vallejo
Colorado
- University of Colorado Cancer Center at UC Health Sciences Center - Aurora
- Memorial Hospital Cancer Center - Colorado Springs - Colorado Springs
- Veterans Affairs Medical Center - Denver - Denver
- Poudre Valley Hospital - Fort Collins
- Front Range Cancer Specialists - Fort Collins
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center - Grand Junction
Georgia
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital - Albany
- Piedmont Hospital - Atlanta
Arkansas
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
Connecticut
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford
Florida
- M.D. Anderson Cancer Center at Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,294 participants |
| Start Date | 1999-04 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00919425
The ClinicalTrials.gov registry entry for NCT00919425 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,294 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 481-participant average among 233 other Leukemia trials with a reported enrollment target (169% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT00919425 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT00919425 about?
NCT00919425 is a clinical study titled "S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer". RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment. PURPOSE: The purpose of this study is to collect and store blood and bone marr...
What is the current status of trial NCT00919425?
This trial is currently completed. The enrollment target is 1,294 participants. The study started on 1999-04. Estimated completion is 2012-01.
What conditions does trial NCT00919425 study?
This clinical trial studies the following conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms.
What interventions are being tested in trial NCT00919425?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT00919425?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00919425 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.